v3.25.2
EQUITY INCENTIVE PLAN (Tables)
12 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF UNVESTED STOCK GRANTS AWARDED AS COMPENSATION

The following table summarizes stock grants awarded as compensation:

 

   # Number of shares   Weighted Average Grant Date Fair Value ($) 
         
Unvested, June 30, 2023   -   $- 
Granted   75,035   $2.24 
Vested   (75,035)  $2.24 
Unvested, June 30, 2024   -   $- 
Granted   120,543   $2.64 
Vested   (120,543)  $2.64 
Unvested, June 30, 2025   -   $- 
SCHEDULE OF COMMON STOCK PURCHASE OPTIONS

 

   # of shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (in years)   Aggregated Intrinsic Value 
                 
Outstanding and exercisable, June 30, 2023   -   $-        $- 
Granted   250,000    2.15    0.5      
Exercised   -    -    -      
Expired / Cancelled   -    -    -      
Outstanding and exercisable, June 30, 2024   250,000   $2.15    0.50   $- 
Granted   50,000    2.94    1.89      
Exercised   (220,000)   2.15    -      
Expired / Cancelled   (30,000)   2.15    -      
Outstanding and exercisable, June 30, 2025   50,000   $2.94    1.89   $8,500 
SUMMARY OF STOCK OPTIONS OUTSTANDING

The following table summarizes information about stock options outstanding and exercisable at June 30, 2025.

 

Exercise Price  Number Outstanding and Exercisable   Weighted Average Remaining Contractual Life   Weighted Average Exercise Price 
OPTIONS:               
                
$2.94   50,000    1.89   $2.94 
Totals   50,000    1.89   $2.94 
SCHEDULE OF SHARE OPTION ASSUMPTIONS

The following table includes the assumptions used in the calculations:

 

 

   June 30, 2025   June 30, 2024 
Risk-free interest rate   3.99%   5.24%
Expected life   1 year    6 months 
Expected volatility   38.8%   63.60%
Expected dividend   0%   0%